Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma-Reference-Cited by-同舟云学术

Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma

Published:2006 Issue:9 Volume:106 Page:1933-1939
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Chi Dennis S.,McCaughty Kristina,Diaz John P.,Huh Jae,Schwabenbauer Sarah,Hummer Amanda J.,Venkatraman Ennapadam S.,Aghajanian Carol,Sonoda Yukio,Abu-Rustum Nadeem R.,Barakat Richard R.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. Cancer Statistics, 2005

2. Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis

3. Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

4. , , . Epithelial ovarian cancer. In , , , , , editors. Principles and Practice of Gynecologic Oncology. 4th ed. Philadelphia, PA: Lippincott-Raven Publishers, 2005: 895–987.

5. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer

Cited by 287 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease after first-line chemotherapy: An ad hoc subgroup analysis of PRIMA/ENGOT-OV26/GOG-3012;Gynecologic Oncology;2024-10

2. Molecular biology as a driver in therapeutic choices for ovarian cancer;International Journal of Gynecologic Cancer;2024-08-28

3. Secondary cytoreduction in recurrent ovarian cancer- experience from a tertiary care centre in India;Gynecologic Oncology Reports;2024-08

4. Recent advancements in management for noncolorectal, nonneuroendocrine hepatic metastases;Journal of Gastrointestinal Surgery;2024-08

5. Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?;Pleura and Peritoneum;2024-07-08